Published in World J Gastroenterol on February 21, 2007
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma. Nat Med (2016) 1.50
Genetic polymorphisms in cytochrome P4502E1, alcohol and aldehyde dehydrogenases and the risk of esophageal squamous cell carcinoma in Gansu Chinese males. World J Gastroenterol (2008) 1.02
Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters. Curr Drug Metab (2010) 0.98
Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997. Nutrition (1999) 3.84
Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer (2001) 3.02
Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer (2002) 2.82
Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu Rev Pharmacol Toxicol (2002) 2.74
Molecular biology of esophageal cancer. Onkologie (2004) 1.28
Drug-metabolizing enzymes: mechanisms and functions. Curr Drug Metab (2000) 1.07
Vitamin intake and risk of subtypes of esophageal cancer in Germany. J Cancer Res Clin Oncol (2002) 1.04
Expression of xenobiotic-metabolizing cytochrome P450 forms in human adult and fetal liver. Biochem Pharmacol (1994) 1.03
Hormone- and substrate-regulated intracellular degradation of cytochrome P450 (2E1) involving MgATP-activated rapid proteolysis in the endoplasmic reticulum membranes. J Biol Chem (1992) 1.03
Cytochrome P450 expression in oesophageal cancer. Gut (1994) 0.98
Expression of cytochrome P 450 3A enzymes in human lung: a combined RT-PCR and immunohistochemical analysis of normal tissue and lung tumours. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.98
Expression of cytochrome P450s and glutathione S-transferases in human esophagus with squamous-cell carcinomas. Carcinogenesis (1996) 0.96
Mechanisms of esophageal cancer development in Brazilians. Mutat Res (2003) 0.95
Quantitative polymerase chain reaction analysis of mdr1 mRNA in multiple myeloma cell lines and clinical specimens. Anal Biochem (1993) 0.94
Characterization of cytochrome P450 expression in human oesophageal mucosa. Carcinogenesis (1999) 0.93
Effects of diet and ethanol on the expression and localization of cytochromes P450 2E1 and P450 2C7 in the colon of male rats. Biochem Pharmacol (1996) 0.93
Distribution of cytochrome P450 2C, 2E1, 3A4, and 3A5 in human colon mucosa. BMC Clin Pharmacol (2005) 0.92
Post-transcriptional regulation of rat CYP2E1 expression: role of CYP2E1 mRNA untranslated regions in control of translational efficiency and message stability. Arch Biochem Biophys (2000) 0.92
Substrate-, hormone-, and cAMP-regulated cytochrome P450 degradation. Proc Natl Acad Sci U S A (1990) 0.91
Decreased expression of cytochrome P450 protein in non-malignant colonic tissue of patients with colonic adenoma. BMC Gastroenterol (2005) 0.87
Posttranscriptional elevation of cytochrome P450 3A expression. Biochem Biophys Res Commun (1997) 0.86
The paradoxical effect of acetaminophen on CYP3A4 activity and content in transfected HepG2 cells. Arch Biochem Biophys (2002) 0.85
Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial. Lancet (2001) 3.88
Rhodopsin's carboxy-terminal cytoplasmic tail acts as a membrane receptor for cytoplasmic dynein by binding to the dynein light chain Tctex-1. Cell (1999) 3.30
Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer (2001) 3.02
Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol (2000) 2.36
Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol (1987) 2.28
Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut (2000) 2.07
Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol (1991) 1.91
Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo. J Biol Chem (1999) 1.73
International multicentre trial protocol to assess the efficacy and safety of tenecteplase during cardiopulmonary resuscitation in patients with out-of-hospital cardiac arrest: the Thrombolysis in Cardiac Arrest (TROICA) Study. Eur J Clin Invest (2005) 1.64
Options in the management of esophageal perforation: analysis over a 12-year period. Dis Esophagus (2009) 1.63
Facilitation of early percutaneous coronary intervention after reteplase with or without abciximab in acute myocardial infarction: results from the SPEED (GUSTO-4 Pilot) Trial. J Am Coll Cardiol (2000) 1.63
Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors. Blood (1998) 1.61
Heparin inhibits ligand binding to the leukocyte integrin Mac-1 (CD11b/CD18). Circulation (1999) 1.58
Inhibition of retinol oxidation by ethanol in the rat liver and colon. Gut (2000) 1.53
[18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancer. J Surg Oncol (2010) 1.49
Early adenocarcinoma in Barrett's oesophagus. Br J Surg (1997) 1.42
Interruption of classic CD40L-CD40 signalling but not of the novel CD40L-Mac-1 interaction limits arterial neointima formation in mice. Thromb Haemost (2014) 1.41
Prospective use of glycoprotein IIb/IIIa receptor blockers in the emergency department setting. Ann Emerg Med (1998) 1.39
[Thoracic pain in a power athlete]. Internist (Berl) (1997) 1.39
Is the "candy-wrapper" effect of (32)P radioactive beta-emitting stents due to remodeling or neointimal hyperplasia? Insights from intravascular ultrasound. Catheter Cardiovasc Interv (2001) 1.38
Jejunal microflora in patients with chronic alcohol abuse. Hepatogastroenterology (1984) 1.38
Activation of human peripheral blood mononuclear cells by nonpathogenic bacteria in vitro: evidence of NK cells as primary targets. Infect Immun (2000) 1.38
High volume centers for esophagectomy: what is the number needed to achieve low postoperative mortality? Dis Esophagus (2004) 1.33
Interaction of glutamic-acid-rich proteins with the cGMP signalling pathway in rod photoreceptors. Nature (1999) 1.32
Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler Thromb Vasc Biol (1997) 1.30
Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis. Circulation (2008) 1.28
[Does Charlson-comorbidity index correlate with short-term outcome in patients with gastric cancer?]. Zentralbl Chir (2003) 1.26
Histones: genetic diversity and tissue-specific gene expression. Histochem Cell Biol (1997) 1.25
Prognostic factors of resected adenocarcinoma of the esophagus. Surgery (1995) 1.24
Models of alcoholic liver disease in rodents: a critical evaluation. Alcohol Clin Exp Res (2001) 1.23
Significance of lymph node involvement at the hepatic hilum in the resection of colorectal liver metastases. Br J Surg (1997) 1.23
The personal experience of aging, individual resources, and subjective well-being. J Gerontol B Psychol Sci Soc Sci (2001) 1.22
Prognosis of early esophageal cancer. Comparison between adeno- and squamous cell carcinoma. Cancer (1995) 1.19
Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size. Circulation (2002) 1.16
Fructose induced depletion of liver adenine nucleotides in man. Horm Metab Res (1971) 1.15
[Elimination of errors caused by turbidity in the determination of protein by the biuret method]. Z Klin Chem Klin Biochem (1968) 1.14
(+)-Cyanidanol-3 in the treatment of acute viral hepatitis: a randomized controlled trial. Hepatology (1984) 1.12
More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. RAPID Investigators. Circulation (1995) 1.10
Hepatic zinc content in patients with various stages of alcoholic liver disease and in patients with chronic active and chronic persistent hepatitis. Hepatology (1988) 1.10
Antibody-enhanced thrombolysis: targeting of tissue plasminogen activator in vivo. Proc Natl Acad Sci U S A (1987) 1.10
Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancer. Histol Histopathol (2008) 1.08
Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injury. Arterioscler Thromb Vasc Biol (2000) 1.06
Spermatogenesis proceeds normally in mice without linker histone H1t. Histochem Cell Biol (2000) 1.06
Construction and functional evaluation of a single-chain antibody fusion protein with fibrin targeting and thrombin inhibition after activation by factor Xa. Circulation (2000) 1.05
Expression of the mouse testicular histone gene H1t during spermatogenesis. Histochem Cell Biol (1996) 1.04
A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer. Ann Surg (2010) 1.04
The effect of intravenously administered magnesium on platelet function in patients after cardiac surgery. Anesth Analg (1999) 1.03
GM-CSF: a strong arteriogenic factor acting by amplification of monocyte function. Atherosclerosis (2001) 1.03
Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus. Cancer (1994) 1.01
Evidence for a differential functional regulation of the two beta(3)-integrins alpha(V)beta(3) and alpha(IIb)beta(3). Exp Cell Res (2006) 1.01
Arteriogenesis: mechanisms and modulation of collateral artery development. J Nucl Cardiol (2001) 1.01
Antibody-directed urokinase: a specific fibrinolytic agent. Science (1985) 1.00
[Influence of secretin and pancreozymin on secretion of calcium in the human duodenal juice in normal and impaired pancreas function]. Klin Wochenschr (1970) 0.99
Clinical and biochemical analysis in infection-associated stroke. Stroke (1995) 0.98
Differential effect of immune cells on non-pathogenic Gram-negative bacteria-induced nuclear factor-kappaB activation and pro-inflammatory gene expression in intestinal epithelial cells. Immunology (2004) 0.98
Usefulness of a simple photometric determination of chymotrypsin activity in stools--results of a multicentre study. Clin Biochem (1986) 0.97
Modulation of cytokine release by differentiated CACO-2 cells in a compartmentalized coculture model with mononuclear leucocytes and nonpathogenic bacteria. Scand J Immunol (2004) 0.97
Inhaled nitric oxide inhibits human platelet aggregation, P-selectin expression, and fibrinogen binding in vitro and in vivo. Circulation (1998) 0.96
The role of apoptosis in myocardial ischemia: a critical appraisal. Basic Res Cardiol (2001) 0.96
The modified AFP score: an attempt to make the results of anti-reflux surgery comparable. Br J Surg (1991) 0.96
Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer. Br J Cancer (2004) 0.94
Assessment of reperfusion of the infarct zone after acute myocardial infarction by serial cardiac troponin T measurements in serum. Br Heart J (1994) 0.94
Superparamagnetic iron oxide binding and uptake as imaged by magnetic resonance is mediated by the integrin receptor Mac-1 (CD11b/CD18): implications on imaging of atherosclerotic plaques. Atherosclerosis (2006) 0.94
Induction of endothelin-1 expression by oxidative stress in vascular smooth muscle cells. Cardiovasc Pathol (2001) 0.94
Localization of catalytic and regulatory subunits of cyclic AMP-dependent protein kinases in mitochondria from various rat tissues. Biochem J (1990) 0.94
Induction of rat aortic smooth muscle cell growth by the lipid peroxidation product 4-hydroxy-2-nonenal. Circulation (1998) 0.94
Return of interdigestive motor complex after abdominal surgery. End of postoperative ileus? Dig Dis Sci (1991) 0.94
Plasminogen activator inhibitor type-1 (PAI-1) and its role in cardiovascular disease. Thromb Haemost (1999) 0.93
Thrombolysis: newer thrombolytic agents and their role in clinical medicine. Heart (2003) 0.93
Spermatogenesis in mice is not affected by histone H1.1 deficiency. Exp Cell Res (2000) 0.92
Preoperative staging of gastric cancer as precondition for multimodal treatment. World J Surg (1995) 0.92
Bone morphogenetic protein modulator BMPER is highly expressed in malignant tumors and controls invasive cell behavior. Oncogene (2011) 0.92
Expression of the mouse histone gene H1t begins at premeiotic stages of spermatogenesis. Cell Tissue Res (1998) 0.92
Anticoagulation: the present and future. Clin Appl Thromb Hemost (2001) 0.91
Specific phosphorylation of a protein in calcium accumulating endoplasmic reticulum from rat parotid glands following stimulation by agonists involving cAMP as second messenger. FEBS Lett (1984) 0.91
Influence of feeding fructose on fructose and glucose absorption in rat jejunum and ileum. Res Exp Med (Berl) (1981) 0.91
Parallel secretion of calcium and enzymes by the human pancreas. Digestion (1973) 0.91
Prognostic impact of nodal micrometastasis in early esophageal cancer. Eur J Surg Oncol (2012) 0.91
Stimulatory effect of pancreozymin-cholecystokinin on calcium secretion in pancreatic juice of dogs. Gut (1972) 0.90
Metabolic and functional properties of lactic acid bacteria in the gastro-intestinal ecosystem: a comparative in vitro study between bacteria of intestinal and fermented food origin. Syst Appl Microbiol (2001) 0.90
Aortic valve rupture after blunt chest trauma. Clin Res Cardiol (2006) 0.90
High-volume centers--effect of case load on outcome in cancer surgery. Onkologie (2004) 0.90
[Dabigatran therapy--perioperative management and interpretation of coagulation tests]. Hamostaseologie (2012) 0.90
Enhanced thrombolytic and antithrombotic potency of a fibrin-targeted plasminogen activator in baboons. Circulation (1996) 0.90
The small proteoglycans decorin and biglycan in human articular cartilage of late-stage osteoarthritis. Osteoarthritis Cartilage (2001) 0.89
Augmentation of arterial endothelial cell expression of the plasminogen activator inhibitor type-1 (PAI-1) gene by proinsulin and insulin in vivo. J Mol Cell Cardiol (1998) 0.89
Tumor-necrosis-factor and interleukin-6 response of peripheral blood monocytes to low concentrations of lipopolysaccharide in patients with alcoholic liver disease. Z Gastroenterol (1995) 0.89
Oxidative stress and atherosclerosis: its relationship to growth factors, thrombus formation and therapeutic approaches. Thromb Haemost (1999) 0.89
Analysis of muscle microcirculation in advanced diabetes mellitus by contrast enhanced ultrasound. Diabetes Res Clin Pract (2008) 0.89
Survivin expression in gastric cancer: Association with histomorphological response to neoadjuvant therapy and prognosis. J Surg Oncol (2009) 0.88
4-hydroxynonenal induces apoptosis, NF-kappaB-activation and formation of 8-isoprostane in vascular smooth muscle cells. Basic Res Cardiol (2001) 0.88
Stimulation of pancreatic secretion of enzymes by acute hypercalcaemia in man. Eur J Clin Invest (1973) 0.88
Construction and characterization of a recombinant plasminogen activator composed of an anti-fibrin single-chain antibody and low-molecular-weight urokinase. J Thromb Haemost (2004) 0.88
Alcohol and retinoids. Alcohol Clin Exp Res (2001) 0.88
[Diagnosis of and therapy for gastric cancer--work-flow]. Zentralbl Chir (2009) 0.87